Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China

Tang, ZY; Xu, X; Gao, J; Chen, L; Zhu, QY; Wang, JL; Yan, XY; Chen, BH; Zhu, YM

Chen, BH (通讯作者),Nantong Univ, Dept Pharm, Affiliated Hosp, Nantong, Peoples R China.;Zhu, YM (通讯作者),China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Peoples R China.

FRONTIERS IN PUBLIC HEALTH, 2022; 10 ():

Abstract

ObjectiveTo assess the economic evaluation of margetuximab plus chemotherapy over trastuzumab plus chemotherapy for women with pretreated ERBB2-positi......

Full Text Link